SHBG and breast cancer: The TOLERANT (Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion, NCT06033092) trial aims to verify whether low-dose tamoxifen increases circulating levels of SHBG more than lifestyle intervention with or without intermittent caloric restriction after six months in women at an increased risk of breast cancer.